相关实验视频

Updated: May 11, 2026

Isolation of Double Negative αβ T Cells from the Kidney

Isolation of Double Negative αβ T Cells from the Kidney

Published on: May 16, 2014

SLAMF7通过增强谷氨胺代谢促进TCRαβ+双负T细胞抗瘤活性

Nan Xu^1,2, Peiyang Fang^1,2, Longyang Zhou^1,2

¹Medical Research Center, Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100020, China.

Journal of experimental & clinical cancer research : CR

|October 31, 2025

概括

信号淋巴细胞激活分子因子7 (SLAMF7) 通过代谢重编程和直接相互作用增强双阴性T细胞 (DNT) 抗瘤活性. 这突出了SLAMF7作为改善DNT癌症免疫疗法的关键目标.

科学领域:

免疫学免疫学免疫学
癌症生物学癌症生物学
细胞的新陈代谢

背景情况:

TCRαβ+双阴性T细胞 (DNT) 在癌症免疫治疗中表现有前途,这是由于其强大的抗瘤活性和缺乏移植对宿主疾病.
控制DNT抗瘤功能的精确机制尚未完全理解.
研究DNT活动的新型调节剂对于推进采用性T细胞疗法至关重要.

研究的目的:

调查信号淋巴细胞激活分子因子7 (SLAMF7) 在调节DNT抗瘤功能的作用.
阐明SLAMF7影响DNT细胞毒性的分子机制.
评估SLAMF7作为增强DNT介导癌症治疗的潜在治疗标.

主要方法:

在小鼠和人类DNT细胞中评估SLAMF7表达.
在体外和体内比较SLAMF7+和SLAMF7-DNT细胞的抗瘤活性.
利用代谢学分析揭示了SLAMF7介导的DNT细胞毒性机制.

主要成果:

在激活后,SLAMF7表达在DNT细胞上显著增加.
与SLAMF7-DNT细胞相比,SLAMF7+ DNT细胞显示出增强的抗瘤能力.
SLAMF7通过连体独立 (通过ERK信号调节谷氨酸代谢) 和连体依赖 (SLAMF7-SLAMF7相互作用促进脱粒) 途径促进抗瘤活性.
在人类DNT细胞中验证了SLAMF7的双重抗瘤作用.

结论:

SLAMF7是DNT中介细胞毒性的关键调节者.
在癌症治疗中,SLAMF7代表了增强DNT细胞功能的有前途的治疗标.
向SLAMF7可能会提高采用DNT免疫疗法的疗效.

关键词:

癌症免疫疗法癌症免疫疗法双阴性T细胞是双阴性T细胞.埃尔克·埃尔克是什么意思谷氨胺的代谢过程在SLAMF7中.

更多相关视频

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

相关概念视频

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...